Which Medical Device Standards Should You Monitor?

You open the standards list. Risk management? Makes sense. Quality management? Expected. Usability, software lifecycle, electrical safety, biocompatibility, sterilization, labeling, and cybersecurity all seem plausible.

Then the questions start. Why is there a standard linked to a market nobody remembers entering? Why does another seem to belong to an older product generation? Why is one reference still monitored, even though nobody can explain what it supports?

This is one of the most common problems with medical device standards lists: over time, they become a mix of deliberate choices, inherited references, old submission logic, and entries nobody felt comfortable deleting.

The question then becomes:
Which standards should we actually monitor?

The thing is: there is no useful universal answer.
A standards list cannot be built properly in isolation from the product it’s supposed to support.
Relevant standards depend on what the device is, what it does, who uses it, which technologies it contains, where it will be marketed, and what kind of regulatory and technical evidence the manufacturer needs to generate.

Think of standards selection as a mapping exercise.

In practice, every standard should be able to answer a simple question:
What exactly put you on this list?

The product, the market, a regulatory pathway, a technical requirement, or the evidence strategy should provide the answer. If something else does, fine, but that reason should still be visible.

Once that mapping is clear, standards monitoring becomes much easier to explain, review, update, and defend without reconstructing the logic from scratch every time someone opens the list.

1. What Should You Know About Your Product First?

Before searching for another ISO number, start with the thing sitting in front of you:
What is the product?

That sounds almost insultingly obvious, but standards decisions often become messy precisely because teams skip straight to familiar standards families before fully defining the device context.

A meaningful standards assessment starts with questions such as:

• What is the intended purpose?

• Who are the intended users?

• What patient population is involved?

• What are the indications and contraindications?

• Where will the device be used?

• What technologies does it rely on?

• How does it operate?

• What claims are being made?

• What is the device classification?

• What is its overall risk profile?

Then the technical characteristics start narrowing the field.

Does the device contain software or use AI or machine-learning functionality? Is it electrically powered? Does it contact the human body? Is it supplied sterile or need to be reprocessed? Is it connected to a network, handling sensitive health data, or interacting with other equipment?

Each answer may point toward particular standards families, test methods, processes, or technical expectations.

The important word here is may.

Technology can point toward relevant standards families, but it should not be treated as an automatic trigger. Software may point toward lifecycle or cybersecurity standards, electrical components toward safety and electromagnetic compatibility, and sterility toward sterilization or packaging standards.

But relevance still depends on the actual product, its intended purpose, design, risks, regulatory pathway, and target market.
This matters because standards lists often become bloated through category thinking: software means adding every software-related standard, patient contact means adding everything connected to biocompatibility, and cybersecurity means adding references without asking what role they actually play.

The better filter is whether a standard has a job to do for this particular device: technically, regulatorily, or both.

2. Which Markets Should Shape Your Standards List?

Once the product context is clear, the next major filter is geography.
Where is the device sold? Where will it be sold? Which regulatory pathways are currently relevant?

A manufacturer working only under the EU MDR or IVDR may need a different standards strategy from a company preparing submissions in the United States, Brazil, China, Japan, or several MDSAP jurisdictions at once.

International standards often overlap significantly across markets. What changes is the regulatory context around them.

Most jurisdictions define what is expected from a medical device through detailed regulatory or legal requirement lists, such as essential requirements or general safety and performance requirements.

This is where standards come into play. Regulations often describe requirements at an abstract level, for example that a manufacturer needs to have risk management in place. A standard such as ISO 14971 then provides a structured way to address, document, and demonstrate that risk management process.

A standard may be:

• harmonized in the EU,

• recognized by the FDA,

• referenced by another national authority,

• expected by a test laboratory,

• relevant to a local submission,

• or technically useful without carrying a specific formal recognition status.

The same document can therefore play different roles in different markets.

And this is where standards lists become much more interesting than a spreadsheet column called Country would suggest!

Imagine a manufacturer that says: “We only sell in the EU.” You open the standards list and find several Chinese or Brazilian standards.
Wrong? Not necessarily. Worth asking about? Absolutely.

Maybe there is a perfectly good reason: a supplier, a future submission, or some useful technical insight. Or maybe the standards were carried over from an old product file and nobody has reviewed why they are still there.

Non-target-market standards are not automatically suspicious. Unexplained ones are!
If a reference relates to a market the company no longer targets, a discontinued submission, or a historical requirement, that context should be visible.

Otherwise, the list slowly becomes a geographical scrapbook: charming in travel, way less useful in regulatory affairs.

3. Which Standards Families Are Actually Relevant?

Once product and market are understood, teams can begin identifying likely standards families.

Some categories appear again and again in medical device work, including:

• quality management systems,

• risk management,

• usability engineering,

• software lifecycle processes,

• electrical safety and electromagnetic compatibility,

• biological evaluation,

• sterilization,

• clinical investigation or performance evaluation,

• labeling and symbols,

• cybersecurity,

• AI-related standards where applicable.

These categories are useful starting points; they just shouldn’t become automatic shopping lists.

Some standards are broadly relevant across large parts of the medical device industry. Others apply only to particular product categories, technologies, processes, materials, risks, or jurisdictions.

“Commonly relevant” doesn’t mean “automatically applicable to every device in every market.”

A manufacturer may use a quality management standard across the organization, while a particular product line also requires standards dealing with electrical safety, software, or sterilization. Another manufacturer may have no electrical components whatsoever. An IVD manufacturer may face a very different combination of performance, laboratory, software, usability, and risk-management considerations.

Even within the same standards family, scope can change the picture.
So keep the question anchored to the device: What role would this standard actually play?

Perhaps it supports a company-wide process, a design requirement, a verification method, a risk-control measure, a test strategy, a regulatory claim, a submission expectation, or a state of the art assessment.
And if nobody can answer that question, the entry may deserve another look.

4. Are All Standards on Your List Doing the Same Job?

A medical device standards list often contains several fundamentally different types of standards. Treating them all as one homogeneous category makes the list harder to understand.

a) Process or QMS standards

These can shape how an organization manages quality, risk, development activities, documentation, suppliers, or other processes across products or departments. Their relevance may extend far beyond one particular device.

b) Product-specific standards

These relate more directly to the characteristics, safety, performance, or testing of a particular device or device family. They often sit closer to design verification, validation, testing, or product-specific technical documentation.

c) Technology-specific standards

These become relevant because of technical characteristics such as software, electrical systems, wireless connectivity, cybersecurity exposure, AI functionality, biological contact, or sterilization. The technology points toward possible relevance; applicability still has to be assessed.

Market context can change what a standard does

A standard may be internationally developed and technically relevant to a device, but its regulatory role can differ by market.

In the EU, harmonized standards may support presumption of conformity for the requirements they cover. In the US, FDA-recognized consensus standards may support regulatory submissions in specific ways. Other markets may have their own recognition, adoption, or expectation mechanisms.

And yes, these categories can overlap:
A standard may be international in origin, relevant to a particular technology, recognized in one market, and used internally for a product-specific verification activity.
Welcome to standards management! Apparently one label would have been too easy.

What matters is understanding why the standard is on the list and what function it serves:
A risk management standard and an electrical safety standard don’t play the same role. One may shape a process across the entire lifecycle; the other may support product-specific testing and verification.

If both simply appear as equal rows without context, the standards list hides information that the team actually needs.

5. Beware the Inherited Standards List

Very few manufacturers build every standards list from an entirely blank page. And that is usually a good thing!

Previous products, earlier submissions, technical files, company procedures, test reports, supplier requirements, and legacy lists can all provide valuable starting information.

The important bit is starting.
Because the problem begins when inheritance replaces assessment.

A standards list can pick up all kinds of baggage over time: references from older products, markets that quietly dropped off the roadmap, technologies the current device no longer uses, old submission logic, or the occasional “someone once asked for this, so here we are.”

Removing a standard often feels more consequential than adding one. So entries stay, even when their original purpose is no longer clear.

Eventually, the standards list starts documenting the company’s regulatory history rather than its current product and market strategy.

What you actually need is a current, explainable map of what the product and market strategy require.

Historical or market-specific references may still earn their place, perhaps because of existing certificates, test reports, regulatory commitments, transition strategies, supplier requirements, or state of the art considerations. They just need a rationale that survives slightly better than:

“Someone added this in 2019.”

That may explain how the standard got there.
It does very little to explain why it should still be there.

6. Traceability Beats Accumulation

This brings us back to the central question:
How do you know whether a standard belongs on the list?

A useful first test is surprisingly simple:
Can you trace it to something?

A product or technology. A company process. A target jurisdiction. A regulatory pathway. A verification or validation activity. A technical requirement. A risk-management decision. A submission expectation.
Something that explains why the company cares about it.

Because the goal isn’t to create the world’s longest list of respectable-looking acronyms, tempting though the achievement may be.

Traceability also makes later decisions easier:
When a new edition appears, the team can assess where it matters.
When a market is added, the standards scope can be reviewed deliberately.
When technology changes, affected standards become easier to identify.
And when an auditor asks why a particular document is monitored, the answer does not have to begin with:

“So, historically…”

A Practical Intake Checklist Before Deciding What to Monitor

Before building or reviewing a medical device standards list, run through a short intake check:

• What is the product, and what is its intended purpose?

• Who uses it, for which patient population, and in what environment?

• Which technologies and technical characteristics matter?

• What are the key claims, classification, and risk profile?

• Where is the product sold or planned to be sold?

• Which regulatory pathways apply?

• Which standards are already being monitored?

• Which entries were inherited from older products, submissions, or markets?

• Can every standard be linked to a product, process, technology, jurisdiction, evidence need, or another clear rationale?

That last question tends to reveal quite a lot.
If the answer is “yes”, awesome!
If it is “mostly”, you have a manageable review exercise.
If it is “we have 186 standards and Kevin used to manage this”, there may be some archaeology ahead.

Where Does Standards Monitoring Get Easier?

Once standards are tied back to product, market, technology, and rationale, monitoring becomes far more manageable. A new standard or edition no longer lands in an abstract pile.

Teams can ask which products, markets, processes, technical files, or verification activities it affects and which existing standards it overlaps with or replaces.

That’s also where structured standards management becomes particularly useful.

At Flinn, we built our Regulatory Monitoring around exactly this idea. But a structured system should not replace regulatory judgment or decide automatically which standards apply to every medical device.

It can also help teams see whether their monitoring scope is explainable, whether entries are linked to the right context, and where legacy references, unclear ownership, or unexplained standards may need review.

The regulatory decision still belongs to the manufacturer. The system can make the reasoning easier to see.

So … Which Standards Should You Monitor?

The answer starts before the standards search begins.

More specifically: understand the device first; its intended purpose, users, technologies, claims, classification, and risks. Then look at the markets and regulatory pathways, and from there work out which standards families actually belong in the picture and what job each standard is supposed to do.

Finally, review what is already sitting in the list and ask whether it still belongs there.

A strong standards list earns its credibility through logic, not row count.

Each standard should have a job grounded in the product, process, technology, market, or evidence strategy, ideally for a better reason than “it looked useful once,” “another product used it,” or “nobody wanted to press delete.”

Your standards list should be traceable to your product and your markets, not inherited blindly from the past.

Want to know whether your standards list reflects your actual product and market strategy?
Flinn helps teams structure, monitor, and review standards lists with clearer context and rationale.

Flinn's Regulatory Monitoring keeps your standards list traceable to product, market, and rationale, and does it automatically as standards change.

In the next part of Medical Device Standards Without the Confusion, we’ll look at another deceptively simple question:
ISO, EN ISO, DIN EN ISO, ÖNORM, BS, AFNOR, EVS: which version do you actually need?

Want to find out more about how Flinn handles this? Contact us.